Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib
Daphne A. Haas-Kogan(University of California, San Francisco), David Stokoe(Cancer Research Institute)
Cited by 467
Related Papers
Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro
|The EMBO Journal|1997|145
Targeting Wee1 for the treatment of pediatric high-grade gliomas
|Neuro-Oncology|2013|123
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
|Cancer Research|2019|27